Back to Search
Start Over
New FDA approvals
- Source :
- Drug Utilization Review. Sept, 2003, Vol. 19 Issue 9, p71, 2 p.
- Publication Year :
- 2003
-
Abstract
- These drugs recently received final approval from the U.S. Food and Drug Administration (FDA): * New indication for etanercept (Enbrel), which is manufactured by Immunex Corp. and marketed by Amgen [...]
- Subjects :
- Otitis externa -- Care and treatment
Acute otitis media -- Care and treatment
Drugs -- Dosage and administration
Drugs -- Evaluation
Menopause -- Dosage and administration
Menopause -- Evaluation
Conjugated estrogens -- Evaluation
Conjugated estrogens -- Dosage and administration
Hemophilia -- Care and treatment
Blood coagulation factor VIII -- Evaluation
Blood coagulation factor VIII -- Usage
Barrett's esophagus -- Care and treatment
Antineoplastic agents -- Evaluation
Antineoplastic agents -- Usage
Antimitotic agents -- Evaluation
Antimitotic agents -- Usage
Stature, Short -- Care and treatment
Somatotropin -- Evaluation
Somatotropin -- Usage
Ankylosing spondylitis -- Care and treatment
Etanercept -- Evaluation
Etanercept -- Usage
Health care industry
Pharmaceuticals and cosmetics industries
Enbrel (Medication) -- Evaluation
Humatrope (Medication) -- Evaluation
Photofrin (Medication) -- Evaluation
PremPro (Medication) -- Evaluation
Subjects
Details
- Language :
- English
- ISSN :
- 08848521
- Volume :
- 19
- Issue :
- 9
- Database :
- Gale General OneFile
- Journal :
- Drug Utilization Review
- Publication Type :
- News
- Accession number :
- edsgcl.108112498